Atosiban Versus Placebo in the Treatment of Late Threatened Pre-term Birth
Condition: Preterm Birth Intervention: Drug: Atosiban Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); ZonMw: The Netherlands Organisation for Health Research and Development; Nottingham University Hospitals NHS Trust; Amphia Hospital; ST. Antonius hospital Nieuwegein; Deventer Ziekenhuis; Erasmus Medic al Center; Flevoziekenhuis; Franciscus Gasthuis; Gelre Hospitals; Groene Hart Ziekenhuis; Isala; Leiden University Medical Center; Martini Hospital Groningen; Maxima Medical Center; Medical Centre Leeuwarden; Haaglanden Medical Centre; Maastricht Uni versity Medical Center; Medisch Spectrum Twente; OLVG; Radboud University Medical Center; Rijnstate Hospital; Spaarne Gasthuis; Tergooi Hospital; University Medical Center Groningen; UMC Utrecht; Diakonessenhuis, Utrecht; Ziekenhuisgroep Twente; Zuyde rland Medical Centre; National Maternity Hospital, Ireland Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials